These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14740949)

  • 1. Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii.
    Halstead SB; Marchette NJ
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):5-11. PubMed ID: 14740949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. I. Attributes of uncloned virus at different passage levels.
    Halstead SB; Diwan AR; Marchette NJ; Palumbo NE; Srisukonth L
    Am J Trop Med Hyg; 1984 Jul; 33(4):654-65. PubMed ID: 6476212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. IV. Characterization of a vaccine candidate in fetal rhesus lung cells.
    Halstead SB; Eckels KH; Putvatana R; Larsen LK; Marchette NJ
    Am J Trop Med Hyg; 1984 Jul; 33(4):679-83. PubMed ID: 6476215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. III. Reversion to virulence by passage of cloned virus in fetal rhesus lung cells.
    Halstead SB; Marchette NJ; Diwan AR; Palumbo NE; Putvatana R; Larsen LK
    Am J Trop Med Hyg; 1984 Jul; 33(4):672-8. PubMed ID: 6476214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.
    Eckels KH; Dubois DR; Putnak R; Vaughn DW; Innis BL; Henchal EA; Hoke CH
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):12-6. PubMed ID: 14740950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. II. Attributes of virus cloned at different dog kidney passage levels.
    Halstead SB; Marchette NJ; Diwan AR; Palumbo NE; Putvatana R
    Am J Trop Med Hyg; 1984 Jul; 33(4):666-71. PubMed ID: 6476213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of biologic attributes of Cuban dengue 2 virus after serial passage in primary dog kidney cells.
    Alvarez M; Guzmán MG; Pupo M; Morier L; Bravo J; Rodriguez R
    Int J Infect Dis; 2001; 5(1):35-9. PubMed ID: 11285157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.
    Edelman R; Tacket CO; Wasserman SS; Vaughn DW; Eckels KH; Dubois DR; Summers PL; Hoke CH
    J Infect Dis; 1994 Dec; 170(6):1448-55. PubMed ID: 7995984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue-4 vaccine: neurovirulence, viraemia and immune responses in rhesus and cynomolgus monkeys.
    Angsubhakorn S; Yoksan S; Bhamarapravati N; Moe JB; Marchette NJ; Pradermwong A; Sahaphong S
    Trans R Soc Trop Med Hyg; 1988; 82(5):746-9. PubMed ID: 3252595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.
    Huang CY; Butrapet S; Pierro DJ; Chang GJ; Hunt AR; Bhamarapravati N; Gubler DJ; Kinney RM
    J Virol; 2000 Apr; 74(7):3020-8. PubMed ID: 10708416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. I. Pre-clinical studies.
    Marchette NJ; Dubois DR; Larsen LK; Summers PL; Kraiselburd EG; Gubler DJ; Eckels KH
    Am J Trop Med Hyg; 1990 Aug; 43(2):212-8. PubMed ID: 1975159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
    Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
    BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.
    Kanesa-Thasan N; Edelman R; Tacket CO; Wasserman SS; Vaughn DW; Coster TS; Kim-Ahn GJ; Dubois DR; Putnak JR; King A; Summers PL; Innis BL; Eckels KH; Hoke CH
    Am J Trop Med Hyg; 2003 Dec; 69(6 Suppl):17-23. PubMed ID: 14740951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells.
    Puri B; Nelson WM; Henchal EA; Hoke CH; Eckels KH; Dubois DR; Porter KR; Hayes CG
    J Gen Virol; 1997 Sep; 78 ( Pt 9)():2287-91. PubMed ID: 9292016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53.
    Kinney RM; Butrapet S; Chang GJ; Tsuchiya KR; Roehrig JT; Bhamarapravati N; Gubler DJ
    Virology; 1997 Apr; 230(2):300-8. PubMed ID: 9143286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
    Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
    J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate.
    Kelly EP; Puri B; Sun W; Falgout B
    Vaccine; 2010 Apr; 28(17):3030-7. PubMed ID: 19874927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells.
    Eckels KH; Scott RM; Bancroft WH; Brown J; Dubois DR; Summers PL; Russell PK; Halstead SB
    Am J Trop Med Hyg; 1984 Jul; 33(4):684-9. PubMed ID: 6476216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.
    Butrapet S; Huang CY; Pierro DJ; Bhamarapravati N; Gubler DJ; Kinney RM
    J Virol; 2000 Apr; 74(7):3011-9. PubMed ID: 10708415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.